Peter L Toogood

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.

N. Pryer, D. W. Fry, W. Elliott, 2004, Molecular cancer therapeutics.

A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.

S. Ely, S. Chen‐Kiang, P. Toogood, 2006, Cancer research.